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Abstract
AIM To determine if activation of the ATP-gated P2X7 receptor channel induces phosphatidylserine (PS)
exposure in erythrocytes from multiple dog breeds. METHODS Peripheral blood was collected from 25 dogs
representing 13 pedigrees and seven crossbreeds. ATP-induced PS exposure on canine erythrocytes in vitro
was assessed using a flow cytometric Annexin V binding assay. RESULTS ATP induced PS exposure in
erythrocytes from all dogs studied. ATP caused PS exposure in a concentrationdependent manner with an
EC50 value of 395 μmol/L. The non-P2X7 agonists, ADP or AMP, did not cause PS exposure. The P2X7
antagonist, AZ10606120, but not the P2X1 antagonist, NF449, blocked ATP-induced PS exposure.
CONCLUSION The results indicate that ATP induces PS exposure in erythrocytes from various dog breeds
and that this process is mediated by P2X7 activation.
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Abstract
AIM
To determine if activation of the ATP-gated P2X7 receptor 
channel induces phosphatidylserine (PS) exposure in 
erythrocytes from multiple dog breeds.
METHODS
Peripheral blood was collected from 25 dogs representing 
13 pedigrees and seven crossbreeds. ATP-induced PS 
exposure on canine erythrocytes in vitro  was assessed 
using a flow cytometric Annexin V binding assay.
RESULTS
ATP induced PS exposure in erythrocytes from all dogs 
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Basic Study
studied. ATP caused PS exposure in a concentration-
dependent manner with an EC50 value of 395 µmol/L. 
The non-P2X7 agonists, ADP or AMP, did not cause PS 
exposure. The P2X7 antagonist, AZ10606120, but not 
the P2X1 antagonist, NF449, blocked ATP-induced PS 
exposure.
CONCLUSION
The results indicate that ATP induces PS exposure in 
erythrocytes from various dog breeds and that this 
process is mediated by P2X7 activation.
Key words: Adenosine triphosphate; Dog; P2X1 receptor; 
P2X7 receptor; Phospholipid; Purinergic receptor; Red 
blood cells
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Phosphatidylserine (PS) exposure in erythrocytes 
has potential roles in erythrocyte clearance and thrombus 
formation. Activation of the ATP-gated P2X7 receptor 
channel induces PS exposure in human erythrocytes, but 
whether this process occurs in erythrocytes from other 
mammals remained hitherto unknown. The current study 
shows that extracellular ATP causes PS exposure in dog 
erythrocytes from 13 pedigrees and seven crossbreeds. 
Notably, the current study shows that this process is 
mediated by P2X7 activation. These results suggest that 
P2X7-mediated PS exposure on erythrocytes may have 
important roles in red blood cell biology in dogs.
Faulks M, Kuit TA, Sophocleous RA, Curtis BL, Curtis 
SJ, Jurak LM, Sluyter R. P2X7 receptor activation causes 
phosphatidylserine exposure in canine erythrocytes. World J 
Hematol 2016; 5(4): 88­93  Available from: URL: http://www.
wjgnet.com/2218­6204/full/v5/i4/88.htm  DOI: http://dx.doi.
org/10.5315/wjh.v5.i4.88
INTRODUCTION
Exposure of the plasma membrane lipid, phospha­
tidylserine (PS), to the outer leaflet is an important 
physiological and pathophysiological signal[1]. In ery­
throcytes, PS exposure serves emerging roles in 
the clearance of senescent, damaged and diseased 
erythrocytes from the circulation[2]. Moreover, PS exposure 
can serve as a substrate for thrombin formation and 
incorporation of erythrocytes into thrombi[3]. PS exposure 
also serves as a parameter for stored erythrocyte 
integrity[4] and may be important in the removal of such 
cells following transfusion[5]. Thus, it remains important 
to understand the mechanisms by which PS becomes 
exposed on the surface of erythrocytes.
The P2X7 receptor is a trimeric ligand­gated channel 
activated by extracellular ATP[6] at concentrations at least 
10­fold greater than that required for other purinergic 
receptors[7]. Functional P2X7 has been reported in 
humans, dogs, rodents and other species[8]. P2X7 
and other purinergic receptors, namely P2X1, P2Y1 
and P2Y13, are present on the plasma membrane of 
erythrocytes[9]. P2X7 activation induces PS exposure 
in human erythrocytes[10,11], but it remains unknown if 
P2X7 activation mediates PS exposure in erythrocytes 
from other species. ATP can induce PS exposure in 
erythrocytes obtained from English springer spaniels[12], 
but whether this process occurs in other dog breeds and 
whether it is mediated by P2X7 activation remains to be 
determined. P2X7, however, is present in leukocytes from 
various dog breeds[13,14] suggesting that P2X7 activation 
may mediate PS exposure in canine erythrocytes.
Using a flow cytometric Annexin V binding assay, 
the current study aimed to determine if ATP induces PS 
exposure in erythrocytes from multiple dog breeds and 
whether this process is mediated by P2X7 activation.
MATERIALS AND METHODS
Materials
Nucleotides were from Sigma Chemical Co. (St. Louis, 
MO). AZ10606120 was from Tocris Bioscience (Ellisville, 
MO). NF499 was from Cayman Chemical (Ann Arbor, 
MI).
Blood samples
Peripheral blood was collected from either pedigree 
or crossbreed dogs into VACUETTE lithium heparin 
tubes (Greiner Bio­One, Frickenheisen, Germany). All 
samples were collected from privately owned dogs 
presenting at the Albion Park Veterinary Hospital (Albion 
Park, Australia), with informed consent of owners, 
and in accordance with and approval from the Animal 
and Human Ethics Committees of the University of 
Wollongong (Wollongong, Australia). The animal protocol 
was designed to minimize pain or discomfort to the 
animals, and conducted according to standard veterinary 
practices.
PS exposure assays
Erythrocytes from peripheral blood were isolated and 
resuspended in NaCl medium (147.5 mmol/L NaCl, 2.5 
mmol/L KCl, 5 mmol/L glucose, 20 mmol/L HEPES, 
pH 7.4) at a final haematocrit of 2% as described[12]. 
Erythrocytes were then incubated in 96­well U­bottom 
plates (Greiner Bio­One) in the absence or presence of 
nucleotide (as indicated) for 24 h at 37 ℃/5% CO2. In 
some experiments, erythrocytes were pre­incubated 
in the absence or presence of AZ10606120 or NF449 
for 15 min at 37 ℃ prior to ATP addition. Following 
nucleotide incubation, 20 µL of resuspended erythrocytes 
were washed once in 1 mL Annexin V Binding Buffer 
(BioLegend, San Jose, CA) (450 × g for 3 min) and 
labeled with fluorescein isothiocyanate (FITC)-conjugated 
Annexin V (BioLegend, San Diego, CA) according to the 
manufacturer’s instructions. Data was collected using a 
BD (San Jose, CA) LSR II or LSRFortessa flow cytometer 
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and FACSDiva software. The percentage of Annexin 
V+ cells (PS exposure) was determined using FlowJo 
software (Tree Star, Inc., Ashland, OR).
Statistical analysis
Data is presented as mean ± SD. Statistical comparisons 
were performed using Prism 5 for Mac OS X (GraphPad 
Software, San Diego, CA). Differences between two or 
more groups were compared using a paired student’s 
t­test or an ANOVA (using Tukey’s multiple comparison 
test), respectively. Concentrations curves were fitted 
using the log(agonist) vs normalized response (variable 
slope) method.
RESULTS
To determine if ATP could induce PS exposure in 
erythrocytes in dog breeds other than English springer 
spaniels, erythrocytes, from 25 dogs representing 13 
pedigrees and seven crossbreeds, were incubated in the 
absence or presence of ATP and the percent of Annexin 
V+ cells (PS exposure) determined by flow cytometry. 
Incubation in the absence of ATP led to a mean PS 
exposure of 3.3% ± 3.2% (Figure 1A). In contrast, 
incubation with ATP caused a 25­fold increase in the 
mean PS exposure to 81.0% ± 10.4% (Figure 1A). 
Collectively, this resulted in an average ATP­induced 
PS exposure of 77.7% ± 11.8% (Figure 1B). Notably, 
ATP caused PS exposure in erythrocytes from all dogs 
studied (Figure 1B). ATP incubation also caused visible 
hemolysis compared to cells incubated in the absence 
of ATP (results not shown), but neither this nor other 
changes in erythrocyte morphology were investigated 
further.
To determine if P2X7 activation mediates exposure of 
PS in canine erythrocytes, erythrocytes were incubated 
with increasing concentrations of ATP and subsequent PS 
exposure assessed as described above. ATP induced PS 
exposure in a concentration­dependent manner with a 
maximum response at 2 mmol/L ATP and with an EC50 
value of 395 ± 45 µmol/L (Figure 2A).
To further establish if P2X7 activation mediates PS 
exposure in canine erythrocytes, erythrocytes were 
incubated with ATP, as well as ADP and AMP, which do 
not activate canine P2X7[12,15]. Again ATP caused robust 
PS exposure in erythrocytes compared to erythrocytes 
incubated in the absence of nucleotide (Figure 2B). In 
contrast, ADP and AMP did not induce PS exposure in 
erythrocytes, with binding of Annexin V similar to that 
of erythrocytes incubated in the absence of nucleotide 
(Figure 2B).
Finally, canine erythrocytes were pre­incubated in 
the absence or presence of AZ10606120, which impairs 
canine P2X7[15], or NF449, which impairs human and 
rodent P2X1[16,17], prior to ATP incubation. Pre­incubation 
with AZ10606120 impaired ATP­induced PS exposure 
by 79%, while pre­incubation with NF449 had minimal 
effect on ATP­induced PS exposure (Figure 2C). Neither 
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Figure 1  ATP induces phosphatidylserine exposure in erythrocytes from multiple dog breeds. Erythrocytes, from 17 pedigree and eight crossbreed (X) dogs, in 
NaCl medium were incubated for 24 h at 37 ℃ in the absence or presence of 1 mmol/L ATP. Cells were labeled with FITC-conjugated Annexin V and analyzed by flow 
cytometry. The bars represent group means (A and B). A: The symbols represent the percentage of Annexin V+ erythrocytes, from each dog, following incubation in 
the absence (basal) or presence of ATP; bP < 0.0001 ATP vs basal; B: The symbols represent the percentage of ATP-induced PS exposure in erythrocytes, from each 
dog, determined as the difference in the percentage of Annexin V+ erythrocytes following incubation in the presence and absence of ATP. The broken line represents 
the mean ATP-induced PS exposure from all dogs. The symbols for Staffordshire bull terrier X represent a Staffordshire bull terrier and Australian kelpie cross, 
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in canine erythrocytes is predominately mediated by 
P2X7 activation. First, the EC50 value for ATP­induced PS 
exposure (395 µmol/L) is similar to that observed for 
native and recombinant canine P2X7­mediated cation 
fluxes in English springer spaniel erythrocytes[12,18] and 
transfected HEK­293 cells[15,19], respectively; second, 
the non­P2X7 agonists, ADP and AMP, did not cause PS 
exposure; last, the P2X7 antagonist, AZ10606120, but 
not the P2X1 antagonist, NF449, impaired ATP­induced 
PS exposure. It should be noted that blockade with 
AZ10606120 was not complete indicating that either 
other purinergic receptors have an additional role in 
this process, or that AZ10606120 has limited efficacy 
in the conditions tested and that P2X7 remains solely 
responsible for ATP­induced PS exposure in canine 
erythrocytes. The latter is supported by at least three 
points. First, the concentration response curve for ATP­
induced PS exposure revealed a simple, not biphasic, 
sigmoidal curve suggesting involvement of only one 
purinergic receptor subtype. Second, ATP concentrations 
below 100 µmol/L, which are sufficient to activate other 
ATP­responsive purinergic receptors[7], failed to cause PS 
exposure. Last, ADP, which can activate P2X1, P2Y1 and 
AZ10606120 nor NF449 affected PS exposure in the 
absence of ATP (Figure 2C).
DISCUSSION
The current study demonstrated that ATP induces PS 
exposure in erythrocytes from 25 dogs representing 
13 pedigrees and seven crossbreeds. On average, 
ATP caused PS exposure on 78% of erythrocytes from 
these dogs. This value is similar to that of ATP­induced 
PS exposure previously observed in erythrocytes from 
English springer spaniels (88%)[12]. Combined, these 
data indicate that ATP can induce PS exposure in 
erythrocytes from multiple dog breeds and suggests 
that this is likely to be a common phenomenon in all 
breeds of dogs. Moreover, these data confirm that ATP-
induced PS exposure in canine erythrocytes is about 
six­fold greater than that observed for ATP­induced PS 
exposure in human erythrocytes[12], which corresponds 
to the increased expression and activity of P2X7 in canine 
erythrocytes compared to human erythrocytes[12,18].
Similar to human erythrocytes[10,11], the current 
study also demonstrates that ATP­induced PS exposure 
Figure 2  ATP induces phosphatidylserine exposure in canine erythrocytes in a concentration-dependent manner. Erythrocytes in NaCl medium were 
incubated for 24 h at 37 °C in the absence or presence of ATP (A) or 1 mmol/L nucleotide (B and C) (as indicated). Prior to ATP incubation, cells were pre-incubated 
for 15 min in the absence or presence of 10 µmol/L AZ10606120 (AZ10) or 10 µmol/L NF499 (C). Following nucleotide incubation, cells were labeled with FITC-
conjugated Annexin V and analyzed by flow cytometry (A-C). A: The data represent percent maximum response to 2 mmol/L ATP (mean ± SD, n = 4 dogs); B: The 
data represent mean ± SD (n = 5 dogs); bP < 0.001 ATP vs basal; dP < 0.001 AMP vs ATP; fP < 0.001 ADP vs ATP; C: The data represent mean ± SD (n = 5 dogs); bP 
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P2Y13, but not P2X7[7], all of which are present in human 
or rodent erythrocytes[20­22], did not induce PS exposure.
It remains unknown why the relative amounts of 
P2X7 differ between canine and human erythrocytes, 
but we have previously speculated[12] that this difference 
may be due to alterations in the proteolytic systems 
mediating maturation­associated degradation in 
reticulocytes between these two species. Differences in 
erythrocyte P2X7 activity between these two species are 
unlikely to be due to altered expression of splice variants. 
Previous immunoblotting studies using an antibody 
to the extracellular loop of P2X7, which is predicted to 
bind all known splice variants of canine P2X7 (URL: 
http://www.ncbi.nlm.nih.gov/gene/448778) and human 
P2X7[23,24], demonstrated only the full­length receptor 
in erythrocytes from both species[12]. Notably, the 
lifespans of canine and human erythrocytes are similar 
(approximately 115 d)[25] suggesting that P2X7­induced 
PS exposure in erythrocytes is unlikely to influence the 
removal of senescent cells.
In the current study, ATP caused visible hemolysis 
of canine erythrocytes, however this was not formally 
investigated. We have previously observed that 24 h 
ATP incubation induces a small but significant amount 
hemolysis of erythrocytes from English springer spaniels 
compared to those incubated in the absence of ATP (16% 
vs 1%, respectively)[12]. Future studies are required to 
explore if this ATP­induced hemolysis is mediated by 
P2X7 or other purinergic receptors, such as P2X1 or 
P2Y1, which can also mediate hemolysis[20,21]. Also, it 
remains unknown if 24 h ATP incubation causes other 
changes in erythrocyte morphology. Five minutes 
incubation with 1 mmol/L ATP of beagle erythrocytes 
increases cell viscosity as assessed by filterability of 
packed cells, but not changes in cell shape as observed 
by light microscopy[26]. Therefore, further studies could 
explore if activation of P2X7 or other purinergic receptors 
alters canine erythrocyte morphology.
In conclusion, the current study indicates that P2X7 
activation induces PS exposure in canine erythrocytes 
and that this phenomenon is common to many, if not 
all, dog breeds. The physiological importance of P2X7­
induced PS exposure in canine erythrocytes, as for 
human erythrocytes, remains to be established. The 
tendency of human erythrocytes to undergo ATP­induced 
PS exposure does not change with erythrocyte age[11], 
further supporting the concept that P2X7­induced PS 
exposure in erythrocytes is unlikely to be involved in the 
removal of aged cells. Instead, it remains plausible, that 
P2X7­induced PS exposure in erythrocytes is responsible 
for the clearance of these cells during cell stress, damage 
or disease. Alternatively, but not mutually exclusive to 
this point, P2X7­induced PS exposure in erythrocytes 
may facilitate thrombus formation to promote wound 
healing and immunity during tissue injury or infection, 
or to inadvertently cause vasocclusion in disorders such 
as malaria, sickle cell disease or diabetes. The robust PS 
exposure in canine erythrocytes following P2X7 activation 
will provide a valuable experimental model to understand 
further the role of this receptor in red blood cell biology. 
Finally, whilst PS exposure is routinely reported in canine 
platelets[27,28] and to some extent canine leukocytes[29,30], 
to the best of our knowledge PS exposure in canine 
erythrocytes is limited to our preliminary[12] and current 
observations. Thus, these studies support a rationale for 
exploring the physiological and pathophysiological roles 
and consequences of PS exposure in erythrocytes within 
dogs.
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Exposure of phosphatidylserine (PS) in erythrocytes has roles in erythrocyte 
clearance and thrombus formation. Activation of P2X7 by extracellular 
adenosine triphosphate (ATP) induces PS exposure in human erythrocytes, but 
whether this process occurs in erythrocytes from dogs was unknown. Therefore 
this study aimed to determine if ATP can induce PS exposure in erythrocytes 
from dogs and if so, whether this process is mediated by activation of P2X7.
Research frontiers
The mechanisms by which PS exposure on dog erythrocytes and the function 
of P2X7 on these cells occurs remain poorly characterised. Moreover, there are 
limited reports of PS exposure on dog erythrocytes in any context.
Innovations and breakthroughs
This study demonstrated that extracellular ATP causes PS exposure in 
dog erythrocytes from multiple breeds and that this process is mediated by 
activation of P2X7.
Applications
This study suggests that P2X7-mediated PS exposure on erythrocytes may 
have important roles in red blood cell biology in dogs. This may have potential 
therapeutic or biomarker applications. Moreover, the relatively high amount of 
P2X7-mediated PS exposure on dog erythrocytes may provide a model to study 
this process, including its biological significance, in greater detail.
Terminology
PS is a phospholipid that is predominately localized to the inner layer of the lipid 
bilayer of the plasma membrane of healthy cells, but can become localized to 
the outer layer (exposed) following cellular activation. Annexin V is a PS-binding 
protein that can be conjugated to a fluorescent label and used to study cellular 
PS exposure by fluorescent techniques such as flow cytometry. The P2X7 
receptor is a plasma membrane ligand-gated channel activated by extracellular 
ATP.
Peer-review
It is a well written interesting paper studying ATP-induced PS exposure, 
which has potential roles in erythrocyte clearance and thrombus formation, 
from various dog breeds and showing that this process is mediated by P2X7 
activation.
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